Alumni - Current Positions
If you are an alumnus and your information is not up to date, please contact Aileen Rosales at (212) 746-6250 to provide us with your current information.
(updated 03/2025)
| Name | Year of Graduation | Advisor's Name | Thesis Project | Current Position |
|---|---|---|---|---|
| Juliana Xu | 2004 | Gudas, Lorraine | Functional Studies of REX-1 Target Genes using F9 Teratocarcinoma Stem Cells as a Model System. | Chief Technology Officer, Agria Corporation, NY |
| John Biggins | 2003 | Thorson, Jon | The Mechanism of CalC - A Protein Conferring Self-Resistance to the Antitumor Antibiotic Calicheamicin within micromonospora echinospora ssp. calichensis | Chemical Biologist, LifeMine Therapeutics- Biotechnology Drug Development, Cambridge, MA |
| Barbara Franklin (Gorfajn) | 2003 | Terminal Masters | Update coming soon | |
| Jack Liao | 2003 | Fisher, Robert | PNQALRE, A Novel CDK Family Member, Associates with CDK-Activating Kinase (CAK) in vivo, and is Required for Normal Proliferation of Mammalian Cells in Culture. | Postdoctoral Fellow, The Donaldson-Atwood Cancer Clinic, The Animal Medical Center |
| Tatiana Litvin | 2003 | Buck, Jochen | A Novel Mechanism of Adenylyl Cylcase Activation Conserved from Cyanobacteria to Man | Assistant Director, Office of Patents and Licensing, UMDNJ |
| Pellegrino Magro | 2003 | Bertino, Joseph | The Effect of p14ARF on DHFR and its Implications on Antifolate Drug Sensitivity. | Scientific Director, MedLearning, Inc. |
| Angelo Russo | 2003 | Bertino, Joseph | Examination of the Role of E2F-1 in the Cellular Response to Antimitotic Agents | Associate Medical Director/Medical Writer, Lowe Healthcare Company, Integrated Communications |
| Andrea D. Basso | 2002 | Rosen, Neal | Regulation of Akt Expression and Signaling by the Hsp90 Chaperone. | Associate Principal Scientist, Schering-Plough Research Institute |
| Elizabeth Bolan | 2002 | Scotto, Kathleen | Molecular and Pharmacological Characterization of Mu Opioid Receptor Hetergeneity. | Pharmacologist, FDA |
| Gina Capiaux | 2002 | Bertino, Joseph | A Fusion Protein of Mutant Dihydrofolate Reductase and Mutant Thymidylate Synthase for Conferring Myeloprotection against Methotrexate and 5-Fluorouracil: Characterization and in vivo Analysis. | Sr. Director, Ultragenyx Pharmaceuticals Inc. |
| Francesca Domenech (Wuttke) | 2002 | Laurence, Jaffrey | Inhibition of SDF1 - Mediated Megakaryocyte Migration by HIV gp120: A New Mechanism for HIV - Associated Thrombocytopenia. | Founder and Principal, Asten BioPharma Advisors, LLC, New York, NY |
| Debbie Friedman | 2002 | Scotto, Kathleen | Transcriptional Regulation by Sp1 Family Members. | |
| Paul Moench | 2002 | Terminal Masters | Bristol Myers Squibb Oncology Research | |
| Wendy Roberts | 2002 | Scheinberg, David | Vaccination Against Normal and Neoplastic B Cells with CD20 Peptides | Research Associate, The Rockefeller University, New York, NY |
| Haijuan Yang | 2002 | Pavlevitch, Nikola | Novel Function Unveiled by the Crystal Structure of the BRCA2 Tumor Suppressor. | Research Fellow, Pavlevitch Laboratory, Memorial Sloan-Kettering Cancer Center |